4. Segment information

In line with the management responsibilities and internal management reporting for its strategic decision-making process, Corbion distinguishes between the segments Functional Ingredients & Solutions and Health & Nutrition.

The Functional Ingredients & Solutions segment, comprises three businesses: Food, Biochemicals, and Lactic Acid to our PLA Joint Venture. As a global supplier of advanced ingredient solutions, we address challenges for the world’s leading manufacturers worldwide, utilizing products from our diverse portfolio. We are known as a fermentation powerhouse, excelling in adaptive and tailored blending capabilities, and providing effective, natural alternatives to synthetic ingredients. We have earned our reputation for deep application expertise, reinforced by our state-of-the-art application labs and dedicated technical support teams, catering to the needs of a broad customer base across food and biochemical markets.

The Health & Nutrition segment comprises three units: Nutrition (including omega-3), Pharma, and Biomaterials markets. Being a global supplier firmly committed to improving health and nutrition for humans and animals, we focus our capabilities to meet diverse market needs.

The Discontinued segment comprises Emulsifiers for which the completion of the divestiture was announced on 2 April 2024. Further reference is made to the Discontinued operations section.

Transfer prices between operating segments are on an arm’s length basis in a manner similar to transactions with third parties.

Segment information by business area

Functional Ingredients & Solutions

Health & Nutrition

Continued 1)

Discontinued

Corbion

millions of euros

2025

2024

2025

2024

2025

2024

2025

2024

2025

2024

Income statement information

Net sales

970.4

997.9

297.0

290.2

1,267.4

1,288.1

-

43.9

1,267.4

1,332.0

Operating profit

33.5

10.0

83.0

67.3

116.5

77.3

-

204.5

116.5

281.8

Adjustments to operating profit

5.9

12.0

-3.9

1.4

2.0

13.4

-

-192.5

2.0

-179.1

Adjusted operating profit

39.4

22.0

79.1

68.7

118.5

90.7

-

12.0

118.5

102.7

Alternative non-IFRS performance measures

EBITDA

104.0

79.0

100.5

85.3

204.5

164.3

-

205.2

204.5

369.5

Adjustments to EBITDA

3.7

9.3

-3.9

1.4

-0.2

10.7

-

-192.5

-0.2

-181.8

Adjusted EBITDA

107.7

88.3

96.6

86.7

204.3

175.0

-

12.7

204.3

187.7

Ratios alternative non-IFRS performance measures

EBITDA margin %

10.7

7.9

33.8

29.4

16.1

12.8

-

467.4

16.1

27.7

Adjusted EBITDA margin %

11.1

8.8

32.5

29.9

16.1

13.6

-

28.9

16.1

14.1

1 Includes Functional Ingredients & Solutions and Health & Nutrition

Corbion generates almost all of its revenues from the sale of goods.

Information on the use of alternative non-IFRS performance measures

In the above table and elsewhere in the financial statements a number of non-IFRS performance measures are presented. Management is of the opinion that these so-called alternative performance measures might be useful for the readers of these financial statements. Corbion management uses these performance measures to make financial, operational, and strategic decisions and evaluate performance of the segments.

The alternative performance measures can be calculated as follows:

  • EBITDA is the operating result before depreciation, amortization, and (reversal of) impairment of (in)tangible fixed assets.

  • EBITDA margin is EBITDA divided by net sales x 100.

Segment information by geographical region

Net sales

2025

2024

The Netherlands

36.3

39.9

Rest of EMEA

333.7

312.9

US

460.7

482.4

Rest of Americas

216.3

238.2

Asia

220.4

214.7

Corbion continuing operations

1,267.4

1,288.1

The above sales information is based on the location of the customer.

Non-current assets

2025

2024

The Netherlands

159.1

187.3

Rest of EMEA

34.1

33.0

US

182.3

212.2

Rest of North America

11.1

13.3

Brazil

124.3

116.8

Thailand

279.5

317.5

Rest of Asia

3.9

4.5

Corbion total operations

794.3

884.6

The above information is based on the geographical location of the assets. Non-current assets exclude those relating to financial instruments, deferred tax assets, and post-employment benefit assets.

At year end 2025, Corbion had a total number of employees (FTEs) of 2,408 of were 632 are located in the Netherlands, 197 in the rest of Europe, 699 in North America, 510 in Latin America and 371 in Asia. At year end 2024, Corbion had a total number of employees (FTEs) of 2,399 of which 623 were located in the Netherlands, 195 in the rest of Europe, 702 in North America, 510 in Latin America and 369 in Asia.